HS Icon Unpackaged Medicaments in  Flag United States

2019
Exports | Imports
: $1.27B | $631M, World Rnk 2 / 155
Flag Rnk 208 / 1217 | World Rnk 4 / 218
Flag Rnk 431 / 1215

2018 - 2019
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $35.1M | $36.9M, Austria |  Sweden

2019
ECONOMIC COMPLEXITY of United States
: 1.59, Rnk 9 / 147

2019
PRODUCT COMPLEXITY  IN Unpackaged Medicaments
: 0.43, Rnk 395 / 1029

Exports: In 2019, United States exported $1.27B in Unpackaged Medicaments, making it the 2nd largest exporter of Unpackaged Medicaments in the world. At the same year, Unpackaged Medicaments was the 208th most exported product in United States. The main destination of Unpackaged Medicaments exports from United States are: Ireland ($529M), Germany ($327M), Canada ($62M), Switzerland ($61.7M), and Netherlands ($53.3M).

The fastest growing export markets for Unpackaged Medicaments of United States between 2018 and 2019 were Austria ($35.1M), Netherlands ($13.7M), and Brazil ($10.4M).

Imports: In 2019, United States imported $631M in Unpackaged Medicaments, becoming the 4th largest importer of Unpackaged Medicaments in the world. At the same year, Unpackaged Medicaments was the 431st most imported product in United States. United States imports Unpackaged Medicaments primarily from: Switzerland ($102M), Portugal ($53M), India ($51.2M), China ($51M), and Germany ($50.9M).

The fastest growing import markets in Unpackaged Medicaments for United States between 2018 and 2019 were Sweden ($36.9M), Portugal ($19.4M), and Austria ($5.86M).

Latest Trends (May 2021)

#permalink to section

Overview: In May 2021 United States' Unpackaged Medicaments exports accounted up to $134M and imports accounted up to $52.9M, resulting in a positive trade balance of $81.4M. Between May 2020 and May 2021 the exports of United States'   Unpackaged Medicaments have decreased by $-7.58M (-5.34%) from $142M to $134M, while imports decreased by $-5.36M (-9.2%) from $58.3M to $52.9M.

Destinations: In May 2021, Unpackaged Medicaments were exported mostly to Ireland ($44.1M), Germany ($37.7M), Canada ($10.6M), United Kingdom ($9.35M), and Switzerland ($7.56M), and were imported mostly from Portugal ($12.1M), Germany ($9.34M), China ($7.41M), Ireland ($5.74M), and India ($5.18M).

Growth: In May 2021, the decrease in Unpackaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Ireland ($-25.8M or -36.9%), Sweden ($-10.7M or -95.6%), and Italy ($-3.65M or -99.6%). In May 2021, the decrease in Unpackaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Ireland ($-12.7M or -68.9%), Italy ($-5.35M or -92.7%), and South Korea ($-2.19M or -97.4%).

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (May 2020 - May 2021): $-7.58M, (-5.34%)

IMPORT GROWTH (May 2020 - May 2021): $-5.36M, (-9.2%)

MAIN EXPORTER (May 2021): Massachusetts, $30.8M

MAIN DESTINATION (May 2021): Ireland, $44.1M

This section shows Unpackaged Medicaments's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Unpackaged Medicaments over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value

EXPORTS (2019): $1.27B

IMPORTS (2019): $631M

NET TRADE (2019): $640M

In 2019, United States exported $1.27B in Unpackaged Medicaments. The main destinations of United States exports on Unpackaged Medicaments were Ireland ($529M), Germany ($327M), Canada ($62M), Switzerland ($61.7M), and Netherlands ($53.3M).

In 2019, United States imported $631M in Unpackaged Medicaments, mainly from Switzerland ($102M), Portugal ($53M), India ($51.2M), China ($51M), and Germany ($50.9M).

Explore Visualizations

IN 2019, United States HAD A POSITIVE NET TRADE IN Unpackaged Medicaments WITH:

IN 2019, United States HAD A NEGATIVE NET TRADE IN Unpackaged Medicaments WITH:

Flow

THE FASTEST GROWING Unpackaged Medicaments EXPORT MARKETS FOR United States WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Unpackaged Medicaments BY United States WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, United States's main exporting competitors in Unpackaged Medicaments were:

In 2018, United States's main importing competitors in Unpackaged Medicaments were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2017, the tariffs for Unpackaged Medicaments in the imports of United States were of 0% around the world.